If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.50 (0.69%)
Bid:
72.00
Ask:
73.00
Spread: 1.00 (1.389%)
Market Cap: £342.04m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Friday broker round-up UPDATE

Fri, 01st Aug 2014 10:33
AstraZeneca: Deutsche Bank ups target price from 3950p to 4000p staying with its hold recommendation.Avacta: Numis places both its target price and its buy recommendation under review.Barclays: Berenberg upgrades from sell to hold with a target price of 220p.Bodycote: UBS shifts target price from 860p to 865p and maintains a buy recommendation.Breedon: Berenberg initiates with a target price of 50p and a buy recommendation.Capita: Credit Suisse lowers target price from 1250p to 1215p and downgrades from outperform to neutral.Computacenter: Jefferies cuts target price from 720p to 690p retaining a hold recommendation.CVS Group: Berenberg starts with a target price of 410p and a buy recommendation.Daily Mail & General Trust: Numis shifts target price from 1180p to 1185p and stays with its buy recommendation.Diageo: Canaccord Genuity reduces target price from 1835p to 1540p downgrading from hold to sell.Dignity: Berenberg initiates with a target price of 1600p and a buy recommendation.Hikma Pharmaceuticals: Jefferies moves target price from 1600p to 1610p and keeps a hold recommendation.IMI: Investec places its target price (prev.: 1570p) under review, while leaving its buy recommendation unchanged.Informa: Goldman Sachs ups target price from 527p to 550p upgrading from sell to neutral.Intu Properties: Deutsche Bank moves target price from 270p to 280p and maintains a hold recommendation.Lancashire Holdings: Credit Suisse reduces target price from 800p to 680p, while leaving its outperform rating unaltered.Lloyds Banking Group: Deutsche Bank shifts target price from 87p to 89p and keeps a buy recommendation.Man Group: Panmure Gordon downgrades from buy to hold with a target price of 125p.Micro Focus: Jefferies raises target price from 420p to 635p, while maintaining an underperform rating.Next: Berenberg raises target price from 7740p to 8075p maintaining a buy recommendation.Parkmead: Numis initiates with a target price of 262p and a buy recommendation.Pennon Group: Credit Suisse moves target price from 645p to 655p and reiterates an underperform rating.PZ Cussons: Panmure Gordon moves target price from 400p to 410p retaining a buy recommendation.Randgold Resources: UBS downgrades from buy to neutral with a target price of 5400p. RBC Capital reduces target price from 5300p to 5200p and stays with a neutral rating.Rightmove: Jefferies reduces target price from 2260p to 2177p keeping a hold recommendation.Rolls-Royce Group: Deutsche Bank cuts target price from 900p to 860p retaining its sell recommendation.Royal Bank of Scotland: Investec ups target price from 325p to 340p, while downgrading from hold to sell.Royal Dutch Shell: Jefferies increases target price from 2460p to 2730p upgrading from hold to buy. UBS raises target price from 2300p to 2450p staying with its neutral rating.RPS Group: Jefferies reduces target price from 385p to 320p, while leaving its buy recommendation unchanged.Schroders: Jefferies raises target price from 2300p to 2500p and reiterates a hold recommendation. Numis cuts target price from 3087p to 3042p retaining its buy recommendation.SDL: Jefferies reduces target price from 620p to 480p, while keeping a buy recommendation.Severn Trent: Credit Suisse increases target price from 1540p to 1730p upgrading to neutral.Smith & Nephew: Investec downgrades from buy to add with a target price of 1100p.UBM: Canaccord Genuity cuts target price from 725p to 680p and retains a hold recommendation.United Utilities: Credit Suisse raises target price from 680p to 730p, while downgrading to underperform.Vesuvius: Investec places both its target price (prev.: 465p) and its add rating under review.Weir Group: Morgan Stanley raises target price from 2440p to 2510p and keeps an equal-weight rating.Zoopla Property: Jefferies initiates with a target price of 325p and a buy recommendation.

Related News

LONDON MARKET CLOSE: FTSE 100 up as DAX hits record high in Frankfurt
13 hours ago

LONDON MARKET CLOSE: FTSE 100 up as DAX hits record high in Frankfurt

(Alliance News) - The FTSE 100 closed a winning week on the front foot, while the DAX 40 hit a new best level, as fears of a US rate increase faded.

WINNERS & LOSERS: JD Sports continues to fall; Close Brothers climbs
20 hours ago

WINNERS & LOSERS: JD Sports continues to fall; Close Brothers climbs

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Avacta Group News

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

IN BRIEF: Avacta Group raises GBP9 million for bond repayments
5 Jun 2026

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...

Avacta to reduce convertible bond debt after £9m placing
5 Jun 2026

Avacta to reduce convertible bond debt after £9m placing

(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
29 May 2026

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

Avacta strengthens oncology position in 2025
19 May 2026

Avacta strengthens oncology position in 2025

(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, w...